The Patent Finder
US

Prodrugs of 2,4-Pyrimidinediamine Compounds and Their Uses

US 7,989,448 Term ended
OverviewFamilyAssignmentsSources & methods
Collateral for a security interest recorded Aug 25, 2022 (Midcap Financial Trust).

Term ended Jun 12, 2026 · High confidence

Filed Nov 10, 2008 as application 12/268,218 · Granted Aug 2, 2011
Base term plus 144 days of patent term adjustment (USPTO delay)
Today
20 years from filing
Term ended Jun 12, 2026
2006 2026
Clock starts
Jan 19, 2006
Term ended
Jun 12, 2026
Granted
Aug 2, 2011
base term patent term adjustment after the term ends fee events Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
144
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 7,449,458, to Jun 12, 2026. The term already ends on or before that date, so the cap shortened nothing.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
13
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term runs 144 days past its 20-year base term on prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. All three maintenance fees were paid, so no fee lapse ended it. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Jan 19, 2006, when application 11/337,049, the earliest non-provisional in its chain, was filed (this one was filed Nov 10, 2008)Jan 19, 2026High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+144 days, USPTO patent term adjustment recordJun 12, 2026High confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 7,449,458)resolves to Jun 12, 2026, no earlier than this term, so no changeHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events3 of 3 maintenance fees paidterm endedHigh confidence
Computed term endThe steps above, in orderJun 12, 2026High confidence

This family

US 7,449,458In force
Sep 2031
Sep 2031
US 7,538,108Term ended
Mar 2026
Mar 2026
US 7,563,892Term ended
Jun 2026
Jun 2026
US 7,989,448this patent
Jun 2026
Jun 2026
US 8,211,888Term ended
Jan 2026
Jan 2026
US 8,211,889Term ended
Jan 2026
Jan 2026
US 8,476,263Term ended
Jan 2026
Jan 2026
US 8,785,437Term ended
no later than Jan 2026
no later than Jan 2026
8 of 13 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jul 14, 2009
Reel 22948, frame 930
Singh, Rajinder; Bhamidipati, Somasekhar; Masuda, EstebanRigel Pharmaceuticlas, Inc.Assignment of Assignor's Interest
Aug 20, 2009
Reel 23132, frame 312
Singh, Rajinder; Bhamidipati, Somasekhar; Masuda, EstebanRigel Pharmaceuticals, Inc.Corrective Assignment to Correct the Assignee Name from Rigel Pharmaceuticlas, Inc. Previously Recorded on Reel 022948 Frame 0930. Assignor(S) Hereby Confirms the Correct Assignee Name Is Rigel Pharmaceuticals, Inc.
Jul 5, 2011
Reel 26543, frame 106
Stella, Valentino J.; Sun, ThomasRigel Pharmaceuticals, Inc.Assignment of Assignor's Interest
Aug 25, 2022
Reel 61327, frame 712
Rigel Pharmaceuticals, Inc.Midcap Financial TrustSecurity Interest
May 8, 2026
Reel 75576, frame 880
Rigel Pharmaceuticals, Inc.Midcap Funding IV TrustSecurity Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited